Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
3643 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Insulin receptor |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
INSR |
SynonymsGene synonyms aliases
|
CD220, HHF5 |
ChromosomeChromosome number
|
19 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
19p13.2 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs1799816 |
C>T |
Benign, likely-benign, uncertain-significance, conflicting-interpretations-of-pathogenicity, benign-likely-benign |
Coding sequence variant, missense variant |
rs41304772 |
C>T |
Conflicting-interpretations-of-pathogenicity |
Coding sequence variant, synonymous variant |
rs52836744 |
C>T |
Pathogenic |
Coding sequence variant, missense variant |
rs121913135 |
C>A |
Pathogenic |
Coding sequence variant, missense variant |
rs121913136 |
T>C |
Pathogenic |
Coding sequence variant, missense variant |
rs121913137 |
G>A,C |
Pathogenic |
Coding sequence variant, missense variant, stop gained |
rs121913138 |
C>A |
Pathogenic |
Coding sequence variant, missense variant |
rs121913139 |
C>T |
Pathogenic |
Coding sequence variant, missense variant |
rs121913140 |
C>G,T |
Pathogenic |
Stop gained, coding sequence variant, missense variant |
rs121913141 |
A>C,G |
Pathogenic |
Coding sequence variant, missense variant |
rs121913142 |
A>C |
Pathogenic |
Coding sequence variant, missense variant |
rs121913143 |
G>T |
Pathogenic |
Coding sequence variant, missense variant |
rs121913144 |
G>A |
Pathogenic |
Coding sequence variant, stop gained |
rs121913145 |
T>C |
Pathogenic |
Coding sequence variant, missense variant |
rs121913146 |
C>T |
Pathogenic |
Coding sequence variant, stop gained |
rs121913147 |
T>C |
Pathogenic |
Coding sequence variant, missense variant |
rs121913148 |
C>T |
Pathogenic |
Coding sequence variant, missense variant |
rs121913150 |
C>T |
Pathogenic |
Coding sequence variant, missense variant |
rs121913151 |
G>A |
Pathogenic, uncertain-significance |
Coding sequence variant, stop gained |
rs121913152 |
A>G |
Pathogenic |
Coding sequence variant, missense variant |
rs121913153 |
C>A,G,T |
Pathogenic |
Coding sequence variant, missense variant |
rs121913154 |
G>A,T |
Pathogenic |
Coding sequence variant, missense variant |
rs121913155 |
T>A |
Pathogenic |
Coding sequence variant, stop gained |
rs121913156 |
C>T |
Pathogenic |
Coding sequence variant, missense variant |
rs121913157 |
C>T |
Pathogenic |
Coding sequence variant, missense variant |
rs121913158 |
C>G |
Pathogenic |
Coding sequence variant, missense variant |
rs121913159 |
G>C |
Pathogenic |
Coding sequence variant, missense variant |
rs121913160 |
T>C |
Pathogenic |
Coding sequence variant, missense variant |
rs138528064 |
G>A |
Likely-benign, conflicting-interpretations-of-pathogenicity |
Coding sequence variant, missense variant |
rs140573575 |
C>A,G,T |
Benign, conflicting-interpretations-of-pathogenicity |
Synonymous variant, coding sequence variant |
rs140852238 |
C>T |
Uncertain-significance, likely-benign, conflicting-interpretations-of-pathogenicity |
Missense variant, coding sequence variant |
rs146588336 |
G>C |
Uncertain-significance, likely-benign, conflicting-interpretations-of-pathogenicity |
Missense variant, coding sequence variant |
rs147125937 |
C>T |
Uncertain-significance, conflicting-interpretations-of-pathogenicity |
Synonymous variant, coding sequence variant |
rs149795690 |
A>G |
Conflicting-interpretations-of-pathogenicity |
Synonymous variant, coding sequence variant |
rs201445608 |
C>G,T |
Conflicting-interpretations-of-pathogenicity |
Synonymous variant, coding sequence variant |
rs267607184 |
C>T |
Pathogenic |
Missense variant, coding sequence variant |
rs376497490 |
G>A,C |
Conflicting-interpretations-of-pathogenicity |
Synonymous variant, coding sequence variant, intron variant |
rs387906538 |
G>A,C |
Pathogenic |
Stop gained, coding sequence variant, missense variant |
rs587776819 |
T>C |
Pathogenic |
Splice acceptor variant |
rs587776820 |
GTCCTGGT>- |
Pathogenic |
Frameshift variant, coding sequence variant |
rs752552480 |
G>A |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs781007453 |
G>A,C |
Pathogenic |
Missense variant, coding sequence variant |
rs797045624 |
A>G |
Pathogenic |
Splice donor variant |
rs886037750 |
C>T |
Pathogenic |
Missense variant, coding sequence variant |
rs1135401737 |
C>A |
Pathogenic |
Coding sequence variant, missense variant |
rs1135401738 |
G>A |
Pathogenic |
Coding sequence variant, missense variant |
rs1135401739 |
C>A |
Pathogenic |
Coding sequence variant, missense variant |
rs1135401740 |
A>C |
Pathogenic |
Coding sequence variant, stop gained |
rs1135401741 |
C>T |
Pathogenic |
Coding sequence variant, missense variant |
rs1135401742 |
T>C |
Pathogenic |
Coding sequence variant, missense variant |
rs1347163319 |
GTTA>- |
Pathogenic |
Frameshift variant, coding sequence variant |
rs1555689937 |
A>G |
Pathogenic |
Coding sequence variant, missense variant |
rs1555735951 |
ATCACTGGCA>CTTCC |
Pathogenic |
Frameshift variant, coding sequence variant |
rs1555736246 |
GATA>- |
Likely-pathogenic |
Frameshift variant, coding sequence variant |
rs1568426700 |
G>A |
Pathogenic |
Coding sequence variant, missense variant |
rs1599874183 |
G>A |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1599881881 |
A>G |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1599937180 |
G>A |
Likely-pathogenic |
Stop gained, coding sequence variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
|
Transcription factors
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0000187 |
Process |
Activation of MAPK activity |
IMP |
17001305 |
GO:0001540 |
Function |
Amyloid-beta binding |
IPI |
19406747 |
GO:0001934 |
Process |
Positive regulation of protein phosphorylation |
IDA |
7556070 |
GO:0002092 |
Process |
Positive regulation of receptor internalization |
IDA |
25401701 |
GO:0003007 |
Process |
Heart morphogenesis |
IMP |
7693131 |
GO:0004713 |
Function |
Protein tyrosine kinase activity |
IDA |
8496180 |
GO:0004713 |
Function |
Protein tyrosine kinase activity |
IMP |
7537849 |
GO:0004714 |
Function |
Transmembrane receptor protein tyrosine kinase activity |
IBA |
21873635 |
GO:0005009 |
Function |
Insulin-activated receptor activity |
IBA |
21873635 |
GO:0005009 |
Function |
Insulin-activated receptor activity |
IDA |
6849137, 8440175 |
GO:0005159 |
Function |
Insulin-like growth factor receptor binding |
IDA |
8452530 |
GO:0005515 |
Function |
Protein binding |
IPI |
7493946, 7537849, 7935368, 8452530, 8702689, 8999839, 9506989, 9593725, 9742218, 10500481, 10660596, 11136729, 11163213, 11279102, 11289049, 11374898, 11506178, 11579209, 11796522, 12237455, 12634852, 14568990, 14722096, 15588987, 15629149, 16582879, 16926280, 17092689, 17135270, 171 |
GO:0005524 |
Function |
ATP binding |
IDA |
6849137 |
GO:0005525 |
Function |
GTP binding |
IDA |
9092559 |
GO:0005635 |
Component |
Nuclear envelope |
IDA |
19406747 |
GO:0005764 |
Component |
Lysosome |
IEA |
|
GO:0005770 |
Component |
Late endosome |
IEA |
|
GO:0005886 |
Component |
Plasma membrane |
IC |
6849137 |
GO:0005886 |
Component |
Plasma membrane |
IDA |
23137377 |
GO:0005886 |
Component |
Plasma membrane |
TAS |
|
GO:0005887 |
Component |
Integral component of plasma membrane |
IBA |
21873635 |
GO:0005887 |
Component |
Integral component of plasma membrane |
IDA |
9092559 |
GO:0005899 |
Component |
Insulin receptor complex |
IBA |
21873635 |
GO:0005899 |
Component |
Insulin receptor complex |
IDA |
1898103 |
GO:0005899 |
Component |
Insulin receptor complex |
IMP |
15069075 |
GO:0005901 |
Component |
Caveola |
IDA |
15182363 |
GO:0005975 |
Process |
Carbohydrate metabolic process |
IEA |
|
GO:0006355 |
Process |
Regulation of transcription, DNA-templated |
IMP |
12881524 |
GO:0006468 |
Process |
Protein phosphorylation |
TAS |
19188609 |
GO:0006898 |
Process |
Receptor-mediated endocytosis |
ISS |
19406747 |
GO:0007169 |
Process |
Transmembrane receptor protein tyrosine kinase signaling pathway |
IBA |
21873635 |
GO:0007186 |
Process |
G protein-coupled receptor signaling pathway |
IDA |
9092559 |
GO:0007275 |
Process |
Multicellular organism development |
IBA |
21873635 |
GO:0007612 |
Process |
Learning |
TAS |
19188609 |
GO:0007613 |
Process |
Memory |
TAS |
19188609 |
GO:0008284 |
Process |
Positive regulation of cell population proliferation |
IC |
11500939 |
GO:0008284 |
Process |
Positive regulation of cell population proliferation |
IDA |
17925406 |
GO:0008284 |
Process |
Positive regulation of cell population proliferation |
IMP |
12138094 |
GO:0008286 |
Process |
Insulin receptor signaling pathway |
IDA |
6849137, 8440175, 20455999 |
GO:0008286 |
Process |
Insulin receptor signaling pathway |
ISS |
19406747 |
GO:0008286 |
Process |
Insulin receptor signaling pathway |
TAS |
|
GO:0009897 |
Component |
External side of plasma membrane |
ISS |
|
GO:0010008 |
Component |
Endosome membrane |
TAS |
|
GO:0014068 |
Process |
Positive regulation of phosphatidylinositol 3-kinase signaling |
IBA |
21873635 |
GO:0016020 |
Component |
Membrane |
IDA |
8452530 |
GO:0018108 |
Process |
Peptidyl-tyrosine phosphorylation |
IDA |
8496180 |
GO:0019087 |
Process |
Transformation of host cell by virus |
IMP |
17001305 |
GO:0019904 |
Function |
Protein domain specific binding |
IPI |
16246733 |
GO:0030335 |
Process |
Positive regulation of cell migration |
IMP |
12138094 |
GO:0030424 |
Component |
Axon |
IBA |
21873635 |
GO:0031981 |
Component |
Nuclear lumen |
IDA |
19406747 |
GO:0031994 |
Function |
Insulin-like growth factor I binding |
IPI |
8452530 |
GO:0031995 |
Function |
Insulin-like growth factor II binding |
IPI |
12138094 |
GO:0032147 |
Process |
Activation of protein kinase activity |
IMP |
9819385 |
GO:0032148 |
Process |
Activation of protein kinase B activity |
IDA |
7556070 |
GO:0032590 |
Component |
Dendrite membrane |
ISS |
|
GO:0032809 |
Component |
Neuronal cell body membrane |
ISS |
|
GO:0032869 |
Process |
Cellular response to insulin stimulus |
IDA |
8440175 |
GO:0033674 |
Process |
Positive regulation of kinase activity |
IBA |
21873635 |
GO:0038024 |
Function |
Cargo receptor activity |
ISS |
19406747 |
GO:0042593 |
Process |
Glucose homeostasis |
IBA |
21873635 |
GO:0042593 |
Process |
Glucose homeostasis |
IMP |
7693131 |
GO:0043235 |
Component |
Receptor complex |
IBA |
21873635 |
GO:0043235 |
Component |
Receptor complex |
IDA |
23382219 |
GO:0043243 |
Process |
Positive regulation of protein-containing complex disassembly |
ISS |
19406747 |
GO:0043410 |
Process |
Positive regulation of MAPK cascade |
IBA |
21873635 |
GO:0043410 |
Process |
Positive regulation of MAPK cascade |
IDA |
20455999 |
GO:0043410 |
Process |
Positive regulation of MAPK cascade |
IMP |
11500939 |
GO:0043548 |
Function |
Phosphatidylinositol 3-kinase binding |
IPI |
7537849, 8276809 |
GO:0043559 |
Function |
Insulin binding |
IDA |
8440175 |
GO:0043559 |
Function |
Insulin binding |
IPI |
8452530 |
GO:0043560 |
Function |
Insulin receptor substrate binding |
IBA |
21873635 |
GO:0043560 |
Function |
Insulin receptor substrate binding |
IPI |
7493946, 7537849, 7559478 |
GO:0044877 |
Function |
Protein-containing complex binding |
IPI |
19406747 |
GO:0045429 |
Process |
Positive regulation of nitric oxide biosynthetic process |
IMP |
10747347 |
GO:0045725 |
Process |
Positive regulation of glycogen biosynthetic process |
IDA |
17925406 |
GO:0045821 |
Process |
Positive regulation of glycolytic process |
IMP |
7693131 |
GO:0045840 |
Process |
Positive regulation of mitotic nuclear division |
IMP |
11500939 |
GO:0045995 |
Process |
Regulation of embryonic development |
IMP |
7693131 |
GO:0046326 |
Process |
Positive regulation of glucose import |
IDA |
3518947 |
GO:0046326 |
Process |
Positive regulation of glucose import |
NAS |
11001060 |
GO:0046777 |
Process |
Protein autophosphorylation |
IDA |
6849137, 8496180 |
GO:0046777 |
Process |
Protein autophosphorylation |
IMP |
7537849 |
GO:0048639 |
Process |
Positive regulation of developmental growth |
IMP |
7693131 |
GO:0051425 |
Function |
PTB domain binding |
IPI |
7559478 |
GO:0051897 |
Process |
Positive regulation of protein kinase B signaling |
IBA |
21873635 |
GO:0051897 |
Process |
Positive regulation of protein kinase B signaling |
IMP |
11500939 |
GO:0060267 |
Process |
Positive regulation of respiratory burst |
IDA |
9092559 |
GO:0070062 |
Component |
Extracellular exosome |
HDA |
20458337 |
GO:0097062 |
Process |
Dendritic spine maintenance |
ISS |
19406747 |
GO:0097242 |
Process |
Amyloid-beta clearance |
ISS |
19406747 |
GO:0150104 |
Process |
Transport across blood-brain barrier |
NAS |
26590417, 30280653 |
GO:1990535 |
Process |
Neuron projection maintenance |
ISS |
|
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
P06213 |
Protein name |
Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] |
Protein function |
Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosine residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway, which is responsible for most of the metabolic actions of insulin, and the Ras-MAPK pathway, which regulates expression of some genes and cooperates with the PI3K pathway to control cell growth and differentiation. Binding of the SH2 domains of PI3K to phosphotyrosines on IRS1 leads to the activation of PI3K and the generation of phosphatidylinositol-(3, 4, 5)-triphosphate (PIP3), a lipid second messenger, which activates several PIP3-dependent serine/threonine kinases, such as PDPK1 and subsequently AKT/PKB. The net effect of this pathway is to produce a translocation of the glucose transporter SLC2A4/GLUT4 from cytoplasmic vesicles to the cell membrane to facilitate glucose transport. Moreover, upon insulin stimulation, activated AKT/PKB is responsible for: anti-apoptotic effect of insulin by inducing phosphorylation of BAD; regulates the expression of gluconeogenic and lipogenic enzymes by controlling the activity of the winged helix or forkhead (FOX) class of transcription factors. Another pathway regulated by PI3K-AKT/PKB activation is mTORC1 signaling pathway which regulates cell growth and metabolism and integrates signals from insulin. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 thereby activating mTORC1 pathway. The Ras/RAF/MAP2K/MAPK pathway is mainly involved in mediating cell growth, survival and cellular differentiation of insulin. Phosphorylated IRS1 recruits GRB2/SOS complex, which triggers the activation of the Ras/RAF/MAP2K/MAPK pathway. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). Isoform Short has a higher affinity for IGFII binding. When present in a hybrid receptor with IGF1R, binds IGF1. PubMed:12138094 shows that hybrid receptors composed of IGF1R and INSR isoform Long are activated with a high affinity by IGF1, with low affinity by IGF2 and not significantly activated by insulin, and that hybrid receptors composed of IGF1R and INSR isoform Short are activated by IGF1, IGF2 and insulin. In contrast, PubMed:16831875 shows that hybrid receptors composed of IGF1R and INSR isoform Long and hybrid receptors composed of IGF1R and INSR isoform Short have similar binding characteristics, both bind IGF1 and have a low affinity for insulin. In adipocytes, inhibits lipolysis (By similarity). |
PDB |
1GAG
,
1I44
,
1IR3
,
1IRK
,
1P14
,
1RQQ
,
2AUH
,
2B4S
,
2HR7
,
2MFR
,
2Z8C
,
3BU3
,
3BU5
,
3BU6
,
3EKK
,
3EKN
,
3ETA
,
3W11
,
3W12
,
3W13
,
4IBM
,
4OGA
,
4XLV
,
4XSS
,
4XST
,
4ZXB
,
5E1S
,
5HHW
,
5J3H
,
5KQV
,
5U1M
,
6HN4
,
6HN5
,
6PXV
,
6PXW
,
6SOF
,
6VEP
,
6VEQ
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF01030 |
Recep_L_domain |
52 → 164 |
Receptor L domain |
Repeat |
PF00757 |
Furin-like |
179 → 340 |
Furin-like cysteine rich region |
Domain |
PF01030 |
Recep_L_domain |
359 → 473 |
Receptor L domain |
Repeat |
PF17870 |
Insulin_TMD |
940 → 987 |
Insulin receptor trans-membrane segment |
Domain |
PF07714 |
PK_Tyr_Ser-Thr |
1023 → 1290 |
Protein tyrosine and serine/threonine kinase |
Domain |
|
Sequence |
|
Sequence length |
1382 |
Interactions |
View interactions |
|
|